Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: A population-based study

Developmental Medicine and Child Neurology

Volumn 44, Issue 4, 2002, Pages 248-255

  Butler, J V ^a   Whittington, J E ^a   Holland, A J ^a   Boer, H ^b   Clarke, D ^b   Webb, T ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BRONCHODILATING AGENT; CARBAMAZEPINE; GROWTH HORMONE; INSULIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BODY WEIGHT; CHILD; CRYPTORCHISM; DISEASE SEVERITY; EARLY DIAGNOSIS; EATING DISORDER; FAMILY; FAMILY HISTORY; FEMALE; FRACTURE; GENETIC ANALYSIS; HEALTH EDUCATION; HUMAN; INCIDENCE; INFANT; LEG ULCER; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MUSCLE HYPOTONIA; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PAIN THRESHOLD; PHYSICAL DISEASE; POPULATION RESEARCH; PRADER WILLI SYNDROME; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; RISK FACTOR; SCOLIOSIS; SEIZURE; SLEEP DISORDER; STRABISMUS;

ADOLESCENT; ADULT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; FRACTURES, BONE; HEALTH STATUS; HUMANS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MIDDLE AGED; PRADER-WILLI SYNDROME; PREVALENCE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SCOLIOSIS; STRABISMUS;

EID: 0036103117     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S001216220100202X     Document Type: Article

References (55)

1. Overview
2. Respiratory disease and Sudden Infant Death Syndrome
3. Obesity in men and women
4. Peculiar body composition in patients with Prader-Labhart-Willi syndrome
5. Obesity increases risk for diabetes
6. Scoliosis: A prospective epidemiological study
7. Prader-Willi Syndrome: Current understanding of cause and diagnosis
8. Growth hormone improves body composition, fat utilisation, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study
9. Osteoporosis in Prader-Willi Syndrome
10. Prader-Willi and Angelman syndromes disorders of genomic imprinting
11. Sleep apnoea in the Prader-Willi syndrome
12. Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation
13. Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome
14. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome
15. Medical issues in adults with Prader-Willi Syndrome
16. Adults with Prader-Willi syndrome: A survey of 232 cases
17. Medical and nursing interventions
18. Scoliosis in Prader-Willi syndrome
19. Pulmonary function abnormalities in Prader-Willi syndrome
20. The origin of excessive daytime sleepiness in the Prader-Willi syndrome
21. Ophthalmologic features of Prader-Willi Syndrome
22. Idiopathic scoliosis and the central nervous system: A motor control problem
23. Understanding the eating disorder affecting people with Prader-Willi syndrome
24. Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome
25. Genetically determined obesity in Prader-Willi syndrome: The ethics and legality of treatment
26. Prader-Willi syndrome and scoliosis
27. Prader-Willi syndrome: Consensus diagnostic criteria
28. Walking compared with vigorous physical activity and risk of type 2 diabetes in women
29. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale
30. Premature coronary artery atherosclerosis in a patient with Prader-Willi syndrome
31. Prader-Willi syndrome after age 15 years
32. Endocrine and metabolic aspects of Prader-Willi syndrome
33. Medical aspects of school-aged children with Down syndrome
34. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably
35. The disease burden associated with overweight and obesity
36. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi Syndrome
37. Imprinting in Prader-Willi and Angelman syndromes
38. Increased bone density after recombinant human growth hormone (gh) therapy in adults with isolated GH deficiency
39. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
40. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustandim Neugeborenenalter
41. Risk factor correlates of body mass index
42. Scoliosis surgery in the Prader-Willi syndrome
43. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes
44. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects
45. Scoliosis in the Prader-Willi syndrome
46. Prader-Willi syndrome and the hypothalamus
47. Health Problems in children with Down's syndrome
48. The incidence of diabetes mellitus in an English community: A 20-year follow-up of the Whickham Survey
49. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes
50. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi Syndrome in one UK Health Region
51. Investigation of thermoregulatory characteristics in patients with Prader-Willi syndrome